All Sections
01
Metabolic & Pancreatic Emergencies
Endocrine — Diabetes Mellitus
Diabetes Mellitus (Type 2) & DKA
| Condition | Best Initial Investigation(s) | First-Line Treatment |
|---|---|---|
| Diabetes Mellitus (Type 2) | HbA1c <5.7% Non-Diabetes HbA1c 5.7–6.4% Pre-Diabetes HbA1c >6.5% Diabetes FPG ≥126 mg/dL · Random Glucose ≥200 + Sx | Lifestyle modification + Metformin |
| Diabetic Ketoacidosis (DKA) | Delirium, Abdominal pain, Kussmaul breathing | 1. IV 0.9% NaCl infusion 2. IV Insulin 3. Potassium replacement |
02
Hypo/Hyperthyroidism, Nodules, Hyperparathyroidism
Thyroid & Parathyroid
Thyroid Disorders
| Condition | Best Initial Investigation(s) | First-Line Treatment |
|---|---|---|
| Hyperthyroidism (Graves') | TSH: Suppressed Free T4 / Free T3: Elevated | Carbimazole / Methimazole Alt: RAI, Surgery |
| Hypothyroidism | TSH: Elevated Free T4: Low | Levothyroxine |
| Thyroid Nodule | TSH + Thyroid Ultrasound | Benign → Observe Malignant/Suspicious → Thyroidectomy |
| Primary Hyperparathyroidism | Serum Calcium: High PTH: High or inappropriately normal | Parathyroidectomy (if symptomatic or meets criteria) |
03
Hypocalcemia, Cushing's, Addison's
Adrenal & Calcium
Adrenal & Calcium Disorders
| Condition | Best Initial Investigation(s) | First-Line Treatment |
|---|---|---|
| Hypocalcemia (Post-Thyroidectomy) | Serum Ionized Ca or Total Ca + Albumin | Acute → IV calcium gluconate Chronic → Oral Calcium + Calcitriol |
| Cushing's Syndrome | 24-hr Urinary Free Cortisol OR Overnight Dexamethasone Suppression Test No suppression | Surgical removal of cause pituitary, adrenal, ectopic |
| Addison's Disease | Morning Cortisol: Low ACTH: High ACTH Stimulation Test: Blunted cortisol | Hydrocortisone + Fludrocortisone |
04
Pheo, Prolactinoma, Acromegaly, SIADH
Pituitary & Pancreatic
Pituitary & Related Disorders
| Condition | Best Initial Investigation(s) | First-Line Treatment |
|---|---|---|
| Pheochromocytoma | Plasma Free Metanephrines OR 24-hr Urinary Fractionated Metanephrines | Pre-op α-blockade Phenoxybenzamine / Doxazosin Definitive → Adrenalectomy |
| Hyperprolactinemia | Serum Prolactin Pituitary MRI (if marked elevation) | Cabergoline / Bromocriptine |
| Acromegaly | IGF-1: Elevated OGTT: GH fails to suppress | Transsphenoidal surgery |
| SIADH | Serum Osmolality: Low Urine Osmolality: High Sodium: Low | 1. Fluid restriction 2. Treat underlying cause |
05
MEN 1, MEN 2A, MEN 2B
Multiple Endocrine Neoplasias
MEN Syndromes
| Condition | Key Features |
|---|---|
| MEN 1 | Pituitary tumors (Prolactin or GH) Pancreatic tumors Parathyroid adenoma |
| MEN 2A | Parathyroid hyperplasia Pheochromocytoma Medullary thyroid carcinoma |
| MEN 2B | Medullary Thyroid Carcinoma Pheochromocytoma Mucosal neuromas · Marfanoid habitus |
Calcium–Phosphate–PTH Differentiation
Ca²⁺ / PO₄ / PTH / ALP Patterns
| Ca²⁺ | PO₄ | PTH | ALP | Condition |
|---|---|---|---|---|
| ↓ | ↓ | ↑ | ↑ | Osteomalacia |
| ↑ | ↓ | ↑ | ↑ | Primary Hyperparathyroidism |
| ↓ | ↑ | ↑ | ↑ | Secondary Hyperparathyroidism (CKD) |
| ↑ | ↓ | ↑↑ | ↑ | Tertiary Hyperparathyroidism |
| ↓ | ↑ | ↑ | ↑ | Pseudohypoparathyroidism |
06
Classic Descriptions & Sounds
Heart Murmurs
Cardiac Murmurs
| Murmur / Sound | Description |
|---|---|
| Aortic Stenosis | Crescendo–decrescendo ejection systolic, radiate to Carotid |
| Mitral Regurgitation | Holosystolic, radiate to Axilla |
| Mitral Valve Prolapse | Systolic click murmur |
| VSD | Holosystolic harsh |
| Aortic Regurgitation | Early diastolic decrescendo |
| Mitral Stenosis | Mid-diastolic murmur |
| PDA | Continuous machine-like murmur |
| ASD | Systolic ejection with wide fixed split S2 |
Heart Sounds
S3 Heart Sound
Rush of blood striking the ventricle wall
→ Dilated Cardiomyopathy
S4 Heart Sound
Atrial contractions against regurgitating blood
→ HOCM
07
Normal Waves & Abnormalities
JVP Waveform
Normal JVP Waves
| Wave | Mechanism |
|---|---|
| a wave | Atrial contraction |
| x wave | Atrial relaxation |
| c wave | Tricuspid valve closure |
| x descent | Passive atrial filling |
| v wave | Venous filling |
| y wave | Atrial emptying |
JVP Abnormalities
| Condition | Abnormality |
|---|---|
| Atrial Fibrillation | Absent a waves |
| Tricuspid Regurgitation | Prominent v wave |
| Constrictive Pericarditis | Prominent x descent |
| Cardiac Tamponade | Absent y descent |
| 3rd Degree Heart Block | Canon a wave |
08
Side Effects to Know
Important Drugs
Drug Side Effects
| Drug | Side Effect |
|---|---|
| ACEI (Captopril) | Dry cough, Angioedema |
| CCB (Nifedipine) | Gingival hyperplasia, Peripheral edema |
| Statin (Simvastatin) | Myositis, Raised CK |
| Procainamide | SLE-like rashes |
| Amiodarone | Thyroid disorder, Pulmonary fibrosis |
| Digoxin | Blurry yellow vision, Hyperkalemia |
| Fibrates | Gallstone |
| Spironolactone | Gynecomastia, Hyperkalemia |
| Nitrates | Monday disease, Impotence |
| Beta Blockers | Impotence |
09
MCV / Iron / TIBC / Ferritin / Transferrin
Anemia Workup
Iron Studies Differentiation
| # | Cause | MCV | Iron | TIBC | Ferritin | Transferrin |
|---|---|---|---|---|---|---|
| 1 | Iron Deficiency | Low | Low | Inc | Low | Low |
| 2 | Thalassemia | Very Low | Inc | Low | Very High | Low |
| 3 | Anemia of Chronic Disease | N/Low | Low | Low | N/High | N/Low |
10
Classic Associations
Translocations & Cancers
Chromosomal Translocations
| # | Translocation | Cancer |
|---|---|---|
| 1 | t(15;17) | AML (M3) — Acute Promyelocytic |
| 2 | t(9;22) | CML — Philadelphia chromosome |
| 3 | t(14;18) | Follicular Cell Lymphoma |
| 4 | t(8;14) | Burkitt Lymphoma |
| 5 | t(11;14) | Mantle Cell Lymphoma |
| 6 | t(11;18) | Marginal Cell Lymphoma |
11
Warm vs Cold
Autoimmune Hemolytic Anemia
Warm AIHA
- Body temperature: normal or raised
- Primarily IgG
- Most common
- Seen in SLE, HIV, Hep C, CLL
- Treatment: corticosteroids
Cold AIHA
- Body temperature: typically low
- Primarily IgM
- Rare
- Mycoplasma pneumoniae & some cancers
- Avoiding cold is crucial
12
Mechanism of Action
Anticoagulants & Antiplatelets
Medications & MOA
| Medication | Mechanism of Action |
|---|---|
| Warfarin | Inhibit synthesis of vitamin K |
| Heparin | Activate antithrombin III |
| Dabigatran (DOAC) | Inhibit directly thrombin |
| Fondaparinux | Inhibit factor Xa |
| Aspirin | Inhibit irreversibly COX-1 → ↓ TXA₂ production |
| Prasugrel | Block P2Y12 receptor on platelet surface → inhibit aggregation |
| Alteplase | Convert plasminogen → plasmin → break down fibrin |
| Tranexamic Acid | Bind to plasminogen → prevent conversion to plasmin |
| Desmopressin | Release VWF → stabilize factor VIII & platelet adhesion |
| Eltrombopag | Activate thrombopoietin receptor → stimulate platelet production |
| Imatinib | Inhibit tyrosine kinase — used in CML |
| Deferoxamine | Bind excess iron → excrete from body |
13
Cadet Mnemonic
O₂–Hemoglobin Dissociation Curve
Right Shift (CADET) — Releases O₂
- C — ↑ CO₂
- A — Acidic pH
- D — ↑ DPG (2,3-BPG)
- E — Exercise
- T — ↑ Temperature
Left Shift — Holds O₂
- ↓ CO₂
- Alkaline pH
- ↓ DPG (2,3-BPG)
- Rest
- ↓ Temperature
14
Initial vs Definitive Investigation
Acute Surgical Diagnoses
Surgical Investigations
| Condition | Best Initial Investigation | Definitive Investigation |
|---|---|---|
| Acute Appendicitis | Ultrasound (USG) | CT Abdomen/Pelvis |
| Cholecystitis | RUQ Ultrasound | HIDA Scan (if USG equivocal) |
| Bowel Obstruction | Abdominal X-ray (AXR) | CT Abdomen/Pelvis |
| Perforated Viscus | Erect Chest X-ray (CXR) | CT Abdomen/Pelvis (with PO contrast) |
| AAA Rupture | Bedside Ultrasound (FAST) | CT Angiography (if stable) |
| DVT | Doppler Ultrasound | Doppler Ultrasound |
| Thyroid Nodule | Thyroid Ultrasound | FNA Biopsy |
| Blunt Abdominal Trauma | FAST Exam | CT Abdomen/Pelvis (if stable) |
| Head Injury | Non-contrast CT Head | Non-contrast CT Head / MRI |
| Renal Colic | Non-contrast CT KUB | Non-contrast CT KUB |
15
Diagnostic Associations
Urine Casts
Casts in Urine
| Cast | Associated Condition |
|---|---|
| Red cast | Malignant HTN, Glomerulonephritis |
| WBC cast | Pyelonephritis, Transplant rejection |
| Fatty cast | Nephrotic syndrome |
| Muddy brown cast | ATN (Acute Tubular Necrosis) |
| Waxy cast | End-stage renal failure |
16
Fanconi, Bartter, Gitelman, Liddle
Tubular Disorders
Renal Tubular Syndromes
| Disease | Key Features |
|---|---|
| Fanconi Syndrome | Defect in PCT · Metabolic acidosis · Rickets |
| Bartter Syndrome | Defect in Loop of Henle · Affects Na⁺/K⁺/2Cl⁻ · AR · Hypokalemia & Hypercalciuria |
| Gitelman Syndrome | Defect of NaCl in DCT · AR · Hypokalemia & Hypocalciuria |
| Liddle Syndrome | Gain of function — ↑ Na reabsorption in collecting tubules · AD · Hypertension & Hypokalemia |
17
Site, MOA & Side Effects
Diuretic Classes
Diuretic Comparison
| Drug Class | Site | Mechanism | Key Side Effects |
|---|---|---|---|
| Carbonic Anhydrase Inhibitors Acetazolamide | PCT | Inhibits carbonic anhydrase → ↓ HCO₃⁻, Na⁺, water reabsorption | Metabolic acidosis, Hypokalemia, Paresthesias, Nephrolithiasis, Drowsiness |
| Osmotic Diuretics Mannitol | PCT & Loop of Henle | ↑ Osmolarity of filtrate → draws water into tubule | Electrolyte imbalance, Headache/nausea, Pulmonary edema, Confusion |
| Loop Diuretics Furosemide · Bumetanide · Torsemide | Thick Ascending Limb | Inhibits NKCC2 (Na⁺-K⁺-2Cl⁻ cotransporter) | Hypokalemia, Hypomagnesemia, Hypovolemia, Ototoxicity, Hyperuricemia |
| Thiazides HCTZ · Chlorthalidone · Indapamide | Early DCT | Inhibits NCC (Na⁺-Cl⁻ cotransporter) | Hypokalemia, Hypercalcemia, Hyperglycemia, Hyperlipidemia, Erectile dysfunction |
| K⁺-Sparing (Aldosterone Antagonists) Spironolactone · Eplerenone | Late DCT & Collecting Duct | Competitively blocks aldosterone → ↓ Na⁺ reabsorption, ↓ K⁺ excretion | Hyperkalemia, Metabolic acidosis, Gynecomastia (spironolactone), Menstrual irregularities |
| K⁺-Sparing (ENaC Blockers) Amiloride · Triamterene | Late DCT & Collecting Duct | Directly blocks ENaC → ↓ Na⁺ reabsorption, ↓ K⁺ excretion | Hyperkalemia, Metabolic acidosis, Nephrolithiasis (triamterene) |
18
Motor, Sensory & Classic Signs
Peripheral Nerve Injuries
Upper Limb Nerves
| Nerve & Site | Mechanism | Motor Deficit | Sensory Deficit | Classic Sign |
|---|---|---|---|---|
| Radial — Axilla | Crutch pressure | Loss of wrist, finger, thumb extension | Radial nerve distribution | Wrist Drop |
| Radial — Mid-shaft Humerus | Spiral groove fracture | Loss of wrist, finger, thumb extension | Dorsum of hand | Wrist Drop |
| Radial — Wrist | Superficial laceration | No motor loss | Anatomical snuffbox | Pure sensory loss |
| Median — Elbow/Forearm | Supracondylar fracture | Loss of thumb opposition, abduction, flexion | Lateral 3½ fingers (palmar) & tips | Ape Hand |
| Median — Wrist (Carpal Tunnel) | Compression in carpal tunnel | Thenar muscle weakness/wasting | Numbness in lateral 3½ fingers (palm spared) | Benediction Hand |
| Ulnar — Elbow | Medial epicondylar fracture | Loss of interossei, lumbricals (3&4), thumb adduction | Medial 1½ fingers (palmar & dorsal) | Claw Hand |
Lower Limb & Shoulder Nerves
| Nerve & Site | Mechanism | Motor Deficit | Sensory Deficit | Classic Sign |
|---|---|---|---|---|
| Axillary — Surgical Neck | Anterior shoulder dislocation | Loss of arm abduction (15–90°) | "Regimental badge" area | Flat Deltoid |
| Musculocutaneous — Upper Arm | Stab wound, trauma | Loss of elbow flexion | Lateral forearm | Weak flexion + weakened supination |
| Common Peroneal — Neck of Fibula | Fracture, tight cast | Loss of dorsiflexion, eversion, toe extension | Dorsum of foot, lateral leg | Foot Drop · Steppage Gait |
| Sciatic — Posterior Hip | Posterior hip dislocation, IM injection | Loss of knee flexion + all below-knee movements | Most of leg & foot | Flail Foot |
| Femoral — Inguinal Region | Pelvic surgery, trauma | Loss of knee extension | — | — |
19
Clinical Outcomes
Cranial Nerve Injuries
Cranial Nerve Lesions
| Cranial Nerve | Clinical Outcome of Injury |
|---|---|
| I — Olfactory | Anosmia (loss of smell) |
| II — Optic | Monocular blindness; Bitemporal hemianopia; Homonymous hemianopia |
| III — Oculomotor | Complete: "Down & Out" eye, ptosis, dilated fixed pupil Pupil-sparing: "Down & Out" + ptosis (pupil normal) |
| IV — Trochlear | Inability to look down when eye is adducted; Vertical diplopia; Head tilt away from lesion |
| VI — Abducens | Medial deviation of eye (loss of abduction); Horizontal diplopia |
| VII — Facial | LMN: Complete ipsilateral facial paralysis (Bell's palsy) UMN: Contralateral lower-face paralysis (forehead spared) |
| X — Vagus | Unilateral: Hoarseness, bovine cough, uvula deviates away from lesion Bilateral: Dysphagia, nasal regurgitation, stridor |
| XI — Spinal Accessory | Weak head turning away from lesion; Shoulder droop; SCM/Trapezius atrophy |
| XII — Hypoglossal | Tongue deviates towards lesion; Fasciculations; Atrophy |
20
Measures of Central Tendency
Biostatistics
Statistical Measures
| Measure | Definition |
|---|---|
| Arithmetic Mean (Average) | The sum of all values divided by the number of values. |
| Median | The middle value when all values are arranged in ascending or descending order. |
| Mode | The value that appears most frequently in a dataset. |
21
Postmortem Changes
Forensic Medicine
Postmortem Changes
| Change | Definition | Example |
|---|---|---|
| Livor Mortis (Lividity) | Settling of blood in lower, dependent parts of the body due to gravity after the heart stops pumping. | Body on back shows purplish-red discoloration on back, buttocks, legs — except pressure areas stay pale. |
| Algor Mortis (Body Cooling) | Gradual cooling of the body after death until it reaches the surrounding environmental temperature. | Warm body in a cool room becomes cold after several hours; cooling rate helps estimate time since death. |
| Rigor Mortis (Body Stiffening) | Postmortem stiffening of muscles due to depletion of ATP and buildup of calcium in muscle fibers. | Joints (jaw, neck, fingers) become stiff; stiffness disappears later as decomposition starts. |
22
Neonatal Jaundice & Muscular Dystrophies
Pediatrics
Physiological Jaundice
- Appears after 24 hours of birth
- Bilirubin increase <5 mg/dL
- Resolves within 10–14 days
- No treatment required
Pathological Jaundice
- Appears within 24 hours after birth
- Bilirubin increase >5 mg/dL per day
- Persists after 14 days
- Needs treatment according to cause
DMD vs BMD
Duchenne vs Becker Muscular Dystrophy
| Variable | DMD | BMD |
|---|---|---|
| Onset | 3–5 years | >10 years |
| Mutation | Absent dystrophin gene | Partial presence of dystrophin gene |
| Gower's Sign | Present | Not common |
| Prognosis | Poor | Good |
23
Clinical Associations
Tumor Markers
Oncology Markers
| Marker | Full Name | Associated Cancer(s) |
|---|---|---|
| PSA | Prostate-Specific Antigen | Prostate Cancer |
| AFP | Alpha-Fetoprotein | HCC; Non-seminomatous Germ Cell Tumors (Yolk sac) |
| CA-125 | Cancer Antigen 125 | Ovarian Cancer (esp. serous) |
| CEA | Carcinoembryonic Antigen | Colorectal; also Pancreatic, Lung, Gastric, Breast |
| CA 19-9 | Carbohydrate Antigen 19-9 | Pancreatic adenocarcinoma; Cholangiocarcinoma |
| hCG | Human Chorionic Gonadotropin | Gestational trophoblastic disease; Testicular (non-seminomatous) |
| β-hCG | Beta-subunit of hCG | Testicular cancer (esp. non-seminomatous) |
| Calcitonin | Calcitonin | Medullary Thyroid Carcinoma |
| Thyroglobulin | Thyroglobulin | Differentiated thyroid cancers (Papillary, Follicular) |
| CA 15-3 / CA 27.29 | Cancer Antigen 15-3 / 27.29 | Breast Cancer |
| LDH | Lactate Dehydrogenase | Germ cell tumors; Lymphoma; Metastatic cancers |
| CgA | Chromogranin A | Neuroendocrine tumors (Carcinoid, Pancreatic NET, Pheo) |
24
Alvarado-like Score
Appendicitis Scoring System
Scoring Criteria (Total = 10)
| Category | Clinical Feature | Points |
|---|---|---|
| Symptoms | Migratory pain to the RIF | 1 |
| Anorexia (loss of appetite) | 1 | |
| Nausea / Vomiting | 1 | |
| Signs | Tenderness in the RIF | 2 |
| Rebound tenderness in the RIF | 1 | |
| Elevated temperature (≥37.3°C) | 1 | |
| Labs | Leukocytosis (High WBC) | 2 |
| Left shift (>75% neutrophils) | 1 |
Action by Score
| Score | Probability | Recommended Action |
|---|---|---|
| 1–4 | Low (Unlikely) | Discharge or evaluate for alternative diagnosis |
| 5–6 | Intermediate (Possible) | Admit for observation ± Ultrasound/CT |
| 7–10 | High (Probable) | Surgical consultation for likely appendectomy |
25
Agent → Antidote Quick Reference
Antidotes
Toxicology Antidotes
| Agent / Toxin | Antidote |
|---|---|
| Coumadin (Warfarin) | Vitamin K |
| Benzodiazepines | Flumazenil |
| Heparin | Protamine Sulfate |
| Magnesium Sulfate | Calcium Gluconate |
| Opiates | Naloxone |
| Cholinergic Medications | Atropine |
| Digoxin | Digibind |
| Acetaminophen | N-Acetylcysteine (NAC) |
| Iron | Deferoxamine |
| Anticholinergics | Physostigmine |
| Beta Blockers | Glucagon |
| Methotrexate | Leucovorin |
| Insulin | Glucose |
| Methanol | Ethanol · Fomepizole |
| Ethylene Glycol | Ethanol · Fomepizole |
| Methemoglobin | Methylene Blue |
| Tricyclic Antidepressants | Sodium Bicarbonate |
| Cyanide | Sodium Thiosulfate |
26
Contusion vs Abrasion vs Laceration
Wound Classification
Wound Comparison
| Feature | Contusion (Bruise) | Abrasion (Graze) | Laceration (Cut/Tear) |
|---|---|---|---|
| Definition | Closed wound from blunt force; damages underlying blood vessels without breaking skin | Superficial open wound; outer layers of epidermis scraped away | Deep open wound; tearing or splitting of skin & underlying soft tissues |
| Mechanism | Blunt trauma (bumping, hitting, squeezing) | Shearing/friction against rough surface | Blunt trauma that tears skin |
| Appearance | Swelling & pain; discoloration (red → blue/purple → green → yellow); skin intact | Raw, weeping surface; debris; minimal bleeding (capillary ooze) | Irregular, jagged margins; bruising/swelling; significant bleeding |
| Layers Involved | Subcutaneous tissue & deeper structures; skin intact | Epidermis (superficial); deeper involve upper dermis | Entire dermis and often subcutaneous tissue, muscle |
| Healing | Heals spontaneously; hematoma if large | High infection risk if not cleaned | High infection risk; often needs stitches; significant scarring |
27
IBD · Hepatitis · Liver Enzymes · Pancreas
GIT & Hepatology
Ulcerative Colitis
- Continuous inflammation from rectum proximally
- Mucosa only · bloody diarrhea, tenesmus
- Pseudopolyps; ↑ colorectal cancer risk
- Associated: PSC; smoking is protective
Crohn's Disease
- Discontinuous skip lesions, mouth to anus
- Transmural → strictures, fistulas, abscesses
- Granulomas on biopsy
- Associated: smoking worsens; perianal disease
Viral Hepatitis Serology
| Type | Transmission | Chronic? | Key Marker |
|---|---|---|---|
| Hepatitis A | Fecal-oral | No | Anti-HAV IgM (acute) |
| Hepatitis B | Blood & body fluids | Yes (5% adults; >90% infants) | HBsAg · anti-HBc IgM (window) · anti-HBs (immunity) · HBeAg (replication) |
| Hepatitis C | Blood (needles, transfusions) | Yes (70–85%) | Anti-HCV |
| Hepatitis D | Requires HBV | Yes (co/superinfection) | Anti-HDV |
| Hepatitis E | Fecal-oral (waterborne) | No | Anti-HEV · high mortality in pregnancy |
Liver Enzyme Patterns
| Pattern | AST / ALT | ALP | Typical Cause |
|---|---|---|---|
| Hepatocellular (viral) | ALT ≥ AST | Normal / Mild ↑ | Acute viral hepatitis |
| Alcoholic liver disease | AST > ALT (≥2:1) | Normal / Mild ↑ | Alcohol |
| Cholestasis | Normal / Mild ↑ | ↑↑ (with GGT) | Obstruction, stones, PBC |
| Ischemic hepatitis | Massive rise (>1000) | Mild ↑ | Shock, hypoxia |
| Cirrhosis | Variable (often AST > ALT) | ↑ | Chronic liver disease |
Cirrhosis Complications
| Complication | Clue | Management |
|---|---|---|
| Ascites / SBP | Tense abdomen; ascitic PMN >250/µL | Paracentesis + albumin; cefotaxime |
| Variceal bleed | Hematemesis, melena | Octreotide + terlipressin; band ligation; TIPS if refractory |
| Hepatic encephalopathy | Asterixis, confusion | Lactulose + rifaximin |
| Hepatorenal syndrome | AKI + ascites without ATN | Terlipressin + albumin; transplant |
| HCC | ↑ AFP or new lesion on surveillance | US + AFP every 6 months; resection/transplant |
Acute Pancreatitis
- Sudden epigastric pain radiating to back
- Lipase >3× ULN (amylase less specific)
- CT with contrast if severe / doubt
- Supportive: IVF, analgesia, NG if ileus; ERCP for gallstone + cholangitis
Chronic Pancreatitis
- Recurrent pain; calcifications on CT
- Steatorrhea, diabetes (exocrine → endocrine)
- MRCP/ERCP for duct anatomy
- Pancreatic enzyme replacement + insulin; pain management
28
Pneumonia · PFTs · Pleural Effusion · TB
Respiratory
Community-Acquired (CAP)
- Typical: S. pneumoniae, H. influenzae; atypicals: Mycoplasma, Legionella
- Outpatient: amoxicillin / macrolide
- Admitted: β-lactam + macrolide
- Severity scores (CURB-65) guide site of care
Hospital-Acquired (HAP)
- ≥48 h after admission; covers MRSA + Pseudomonas
- Empiric: piperacillin-tazobactam or cefepime + vancomycin/linezolid
- VAP: consider on ventilator
- Cultures before antibiotics whenever possible
Obstructive vs Restrictive PFTs
| Parameter | Obstructive | Restrictive |
|---|---|---|
| FEV1 / FVC | ↓ (<0.70) | Normal or ↑ |
| TLC | Normal / ↑ (hyperinflation) | ↓ |
| RV | ↑ | ↓ |
| DLCO | ↓ in emphysema; normal in asthma | ↓ (fibrosis) |
| Prototype | Asthma, COPD, bronchiectasis | IPF, sarcoidosis, neuromuscular |
| Key history | Wheeze, smoking, reversible (asthma) | Dyspnea, dry cough, crackles |
Pleural Effusion — Light's Criteria (Exudate if any)
| Criterion | Exudate | Transudate |
|---|---|---|
| Protein (pleural/serum) | >0.5 | <0.5 |
| LDH (pleural/serum) | >0.6 | <0.6 |
| Pleural LDH | >2/3 upper limit normal | <2/3 |
| Common causes | Infection, malignancy, PE | HF, cirrhosis, nephrotic syndrome |
Primary TB
- Lower / mid zones, Ghon focus
- Hilar lymphadenopathy
- Often asymptomatic; good host immunity
- May progress to miliary if immunocompromised
Secondary TB (Reactivation)
- Apical / upper lobe with cavitation
- Smear positive; highly infectious
- Fever, night sweats, weight loss, hemoptysis
- Latent → RIPE if active
RIPE Regimen
| Drug | Key Side Effect / Note |
|---|---|
| Rifampicin | Orange body fluids; CYP450 inducer; hepatotoxic |
| Isoniazid | Peripheral neuropathy → give pyridoxine (B6); hepatotoxic |
| Pyrazinamide | Hyperuricemia (gout); hepatotoxic |
| Ethambutol | Optic neuritis → red-green color blindness (screen vision) |
29
Bacteria · CSF · Antibiotics · HIV
ID / Microbiology
Gram Positive vs Gram Negative
| Feature | Gram (+) | Gram (−) |
|---|---|---|
| Cell wall | Thick peptidoglycan (retains crystal violet) | Thin peptidoglycan + outer membrane (LPS) |
| Classic examples | Staph aureus, Strep pyogenes, enterococci, Clostridia | E. coli, Klebsiella, Pseudomonas, Neisseria |
| Key toxins | Exotoxins (TSST, erythrogenic toxin) | Endotoxin (LPS) → fever, shock |
Meningitis — CSF Findings
| Type | Cells | Glucose | Protein |
|---|---|---|---|
| Bacterial | PMN ↑↑ | ↓↓ | ↑↑ |
| Viral | Lymphocytes | Normal | Mild ↑ |
| Tuberculous | Lymphocytes | ↓ | ↑↑ |
| Fungal (cryptococcal) | Lymphocytes | ↓ | ↑ |
Antibiotic Mechanisms
| Class | Mechanism |
|---|---|
| β-lactams (penicillins, cephalosporins) | Inhibit cell wall synthesis (transpeptidase / PBPs) |
| Vancomycin | Cell wall — binds D-Ala–D-Ala (Gram + only) |
| Aminoglycosides | 30S ribosome → misreading of mRNA |
| Tetracyclines | 30S ribosome → blocks tRNA binding |
| Macrolides | 50S ribosome → blocks translocation |
| Clindamycin / Linezolid | 50S ribosome (linezolid blocks initiation) |
| Fluoroquinolones | DNA gyrase / topoisomerase IV |
| Sulfonamides + Trimethoprim | Folate synthesis (PABA analog) — sequential block |
| Metronidazole | DNA damage in anaerobes (free radicals) |
| Polymyxins (colistin) | Disrupt outer membrane — last resort |
HIV — Opportunistic Infections by CD4
| CD4 Count | Infection |
|---|---|
| <500 | Candidiasis (oral/vaginal), TB reactivation |
| <200 | Pneumocystis jirovecii (PCP) → TMP-SMX prophylaxis |
| <100 | Toxoplasma encephalitis, Cryptococcal meningitis |
| <50 | CMV retinitis, MAC (Mycobacterium avium complex) |
30
APGAR · Hypertensive Spectrum · Ectopic · CTG
OB / GYN
APGAR Score (at 1 & 5 minutes)
| Component | 0 | 1 | 2 |
|---|---|---|---|
| Appearance | Blue / pale | Body pink, extremities blue | All pink |
| Pulse | Absent | <100/min | ≥100/min |
| Grimace (reflex irritability) | No response | Grimace | Cry / cough |
| Activity (tone) | Limp | Some flexion | Active movement |
| Respiration | Absent | Slow, irregular | Good, crying |
Hypertensive Disorders of Pregnancy
| Disorder | Definition | Key Point |
|---|---|---|
| Gestational HTN | BP ≥140/90 after 20 weeks, no proteinuria | Monitor closely |
| Preeclampsia | Gestational HTN + proteinuria or end-organ dysfunction | MgSO₄ seizure prophylaxis; deliver |
| Severe features | BP ≥160/110, platelets <100K, renal/hepatic/neuro | Deliver once stabilized |
| Eclampsia | Seizures in preeclampsia | MgSO₄ first-line; delivery |
| HELLP | Hemolysis, Elevated Liver enzymes, Low Platelets | Severe variant — deliver |
Ectopic Pregnancy
| Aspect | Key Facts |
|---|---|
| Risk factors | Previous ectopic, PID, IUD, IVF, tubal surgery |
| Presentation | Amenorrhea + pain + bleeding; ruptured → shock |
| Diagnosis | TVS (empty uterus) + abnormal/plateau hCG rise |
| Management | Stable & small → methotrexate; rupture → salpingectomy |
CTG Decelerations
| Pattern | Cause | Action |
|---|---|---|
| Early deceleration | Head compression (benign) | Observe |
| Variable deceleration | Cord compression | Reposition mother; amnioinfusion if refractory |
| Late deceleration | Uteroplacental insufficiency | Oxygen, left lateral, delivery if persists |
| Category III | Fetal compromise (abnormal baseline + recurrent decels) | Expedite delivery |
31
Hypersensitivity · Rejection · Primary Immunodeficiencies · Vaccines
Immunology
Hypersensitivity Reactions (Gell & Coombs)
| Type | Mechanism | Classic Examples |
|---|---|---|
| I — Anaphylactic | IgE + mast cells / basophils | Anaphylaxis, allergic rhinitis, asthma, food allergy |
| II — Cytotoxic | IgG/IgM against cell surface | AIHA, ITP, Goodpasture, ABO transfusion reaction |
| III — Immune complex | IgG/IgM + antigen deposits | SLE, serum sickness, post-strep GN |
| IV — Delayed (T cell) | Sensitized T cells (TH1 / CTL) | Contact dermatitis, PPD, transplant rejection, granulomas |
Transplant Rejection
| Type | Timing | Mechanism |
|---|---|---|
| Hyperacute | Minutes–hours | Preformed antibodies → vascular thrombosis |
| Acute cellular | Days–weeks | T cells infiltrate the graft |
| Acute humoral | Days–weeks | Antibodies against graft endothelium |
| Chronic | Months–years | Fibrosis / atherosclerosis, ischemia |
| GVHD | Weeks | Donor T cells attack recipient (bone marrow transplant) |
Primary Immunodeficiencies
| Defect | Disease | Hallmark |
|---|---|---|
| B cells | X-linked agammaglobulinemia (Bruton) | No B cells / low Ig; infections after 6 months (maternal IgG wanes) |
| T cells / thymus | DiGeorge (22q11 deletion) | Absent thymus, hypocalcemia, cardiac defects |
| B/T (late) | CVID | Low IgG/IgA/IgM, adult onset, recurrent infections |
| IgA | Selective IgA deficiency | Most common; anaphylaxis to blood products |
| B/T (severe) | SCID | Failure to thrive, severe infections in infancy |
| Phagocyte | Chronic granulomatous disease | NADPH oxidase defect; catalase(+) abscesses (Staph, Aspergillus); abnormal NBT test |
Live Attenuated
- MMR, varicella, rotavirus, yellow fever, nasal flu (LAIV), BCG, oral polio
- Contraindicated in pregnancy & severe immunosuppression
- Can shed in immunocompromised household
Inactivated / Killed
- Flu shot (IIV), IPV, rabies, hepatitis A & B, HPV, pneumococcal
- Generally safe in pregnancy & immunocompromised
- May need boosters; killed organism cannot cause disease
32
Arches · Pouches · Teratogens · Fetal Circulation
Embryology
Pharyngeal (Branchial) Arches
| Arch | Nerve | Major Derivative |
|---|---|---|
| 1st | CN V₃ (mandibular) | Meckel cartilage → maxilla, mandible, malleus/incus; muscles of mastication |
| 2nd | CN VII (facial) | Reichert cartilage → stapes, styloid process; muscles of facial expression |
| 3rd | CN IX (glossopharyngeal) | Hyoid bone (greater horn), stylopharyngeus |
| 4th & 6th | CN X (vagus) | Laryngeal cartilages & muscles; arch 4 → aortic arch, arch 6 → ductus arteriosus |
Pharyngeal Pouches
| Pouch | Derivative |
|---|---|
| 1st | Middle ear cavity, Eustachian tube |
| 2nd | Palatine tonsils |
| 3rd | Thymus + inferior parathyroids |
| 4th | Superior parathyroids + ultimobranchial body → C cells (calcitonin) |
Classic Teratogens
| Teratogen | Effect |
|---|---|
| Thalidomide | Phocomelia (limb defects) |
| Alcohol | Fetal alcohol syndrome: microcephaly, growth restriction, facial dysmorphism, intellectual disability |
| Retinoic acid (isotretinoin) | CNS & cardiac defects |
| Warfarin | Nasal hypoplasia, stippled epiphyses |
| Valproate | Neural tube defects (spina bifida) → use folate |
| Lithium | Ebstein anomaly (atrialized right ventricle) |
| ACE inhibitors | Renal dysgenesis, oligohydramnios |
| Methotrexate | Multiple anomalies, abortion |
Fetal Circulation — After Birth
| Structure | Closes To |
|---|---|
| Foramen ovale | Fossa ovalis (functional at birth; anatomical ~3 months) |
| Ductus arteriosus | Ligamentum arteriosum (patency kept by prostaglandins; closes as PGE falls) |
| Ductus venosus | Ligamentum venosum |
| Umbilical vein | Ligamentum teres (round ligament of liver) |
| Umbilical arteries | Medial umbilical ligaments |
33
Mood · Psychosis · Delirium vs Dementia · Personality · Anxiety
Psychiatry
Unipolar (MDD)
- Only depressive episodes — no mania/hypomania
- First-line: SSRI + psychotherapy
- Core: low mood, anhedonia, sleep/appetite change, guilt, poor concentration
Bipolar Disorder
- At least one manic (BD-I) or hypomanic (BD-II) episode
- Depression is the common polarity
- First-line: mood stabilizer (lithium/valproate); avoid antidepressant monotherapy (switch risk)
Antipsychotics — Typical vs Atypical
| Feature | Typical (haloperidol) | Atypical (risperidone, olanzapine) |
|---|---|---|
| EPS (dystonia, akathisia, parkinsonism) | High | Low (except high-dose risperidone) |
| Tardive dyskinesia | High | Lower |
| Prolactin ↑ | High (D2 blockade) | Lower |
| Metabolic syndrome | Low | High (olanzapine, clozapine) |
| NMS | Rare, all classes: fever, rigidity, ↑CK → stop + dantrolene/bromocriptine | |
Delirium vs Dementia
| Feature | Delirium | Dementia |
|---|---|---|
| Onset | Acute (hours–days) | Insidious (months–years) |
| Course | Fluctuating | Progressive |
| Consciousness | Impaired / clouded | Clear (until late) |
| Attention | Poor | Relatively preserved |
| Reversible? | Yes (treat cause) | Usually not |
Personality Disorder Clusters
| Cluster | Theme | Disorders |
|---|---|---|
| A — Odd / Eccentric | Suspicious, detached | Paranoid, schizoid, schizotypal |
| B — Dramatic / Erratic | Emotional, impulsive | Antisocial, borderline, histrionic, narcissistic |
| C — Anxious / Fearful | Fear of rejection / need for control | Avoidant, dependent, obsessive-compulsive |
Anxiety Disorders — Key Discriminator
| Disorder | Core Feature |
|---|---|
| GAD | Chronic worry about multiple domains ≥6 months + somatic symptoms |
| Panic disorder | Recurrent unexpected panic attacks + fear of attacks (agoraphobia) |
| Social anxiety | Fear of scrutiny / negative evaluation in social situations |
| Specific phobia | Fear of a specific object/situation → avoidance |
| PTSD | Trauma + re-experiencing + hyperarousal + avoidance (>1 month) |
34
Arthritis · Bone Tumors · Osteoporosis
Musculoskeletal
Arthritis — Rapid Differentiation
| Feature | OA | RA | Gout | Septic |
|---|---|---|---|---|
| Onset | Gradual, age-related | Insidious | Acute overnight | Acute + ill patient |
| Joints | Knees, hips, DIP (Heberden) | MCP, PIP, wrists (symmetric) | 1st MTP (podagra) | Single joint (knee) |
| AM stiffness | <30 min | >1 hour | — | — |
| Synovial fluid | Non-inflammatory | Inflammatory | Urate crystals (neg. birefringent) | PMN >50K; culture (+) |
| Key test | X-ray (joint space loss) | RF / anti-CCP | Serum uric acid (normal possible in flare) | Aspiration, Gram stain + culture |
| Treatment | Analgesia, exercise | DMARDs (methotrexate) | Colchicine, NSAIDs, allopurinol | IV antibiotics + urgent drainage |
Bone Tumors
| Tumor | Age | Site | Radiograph |
|---|---|---|---|
| Osteosarcoma | 10–25 | Distal femur / proximal tibia (metaphysis) | Sunburst / Codman triangle |
| Ewing sarcoma | 5–20 | Diaphysis of long bones; pelvis | Onion-skin periosteal reaction |
| Osteochondroma | 10–30 | Metaphysis (most common benign) | Exostosis with cartilage cap |
| Multiple myeloma | >60 | Axial skeleton (skull, spine, pelvis) | Punched-out lytic lesions; M spike |
| Giant cell tumor | 20–40 | Epiphysis (distal femur, proximal tibia) | Lytic "soap bubble" (after bone maturity) |
Osteoporosis
| T-score | Category | Action |
|---|---|---|
| ≥ −1.0 | Normal | Reassure; calcium + vitamin D |
| −1.0 to −2.5 | Osteopenia | Risk-stratify (FRAX); treat if high risk |
| ≤ −2.5 | Osteoporosis | Treat — bisphosphonates first-line (denosumab / teriparatide alternatives) |
| ≤ −2.5 + fragility fracture | Severe | Treat + fall prevention; reassess adherence |
35
Stroke Territories · Brainstem · UMN vs LMN · Tracts · Seizures
Neurology
Stroke — Vascular Territories
| Artery | Syndrome |
|---|---|
| MCA | Contralateral face/arm > leg; Broca / Wernicke aphasia (dominant); gaze deviation toward lesion |
| ACA | Contralateral leg > arm; apathy, incontinence |
| PCA | Contralateral homonymous hemianopia; visual agnosia, alexia |
| PICA — Lateral medullary (Wallenberg) | Ipsilateral Horner + ataxia + facial pain/temp loss; contralateral body pain/temp loss |
| Basilar | Locked-in syndrome (pons): quadriplegia, preserved consciousness + vertical eye movements |
| Lacunar (small vessel) | Pure motor, pure sensory, or ataxic hemiparesis — no cortical signs |
Brainstem Syndromes
| Level | Syndrome | Findings |
|---|---|---|
| Midbrain | Weber | Ipsilateral CN III (ptosis, down-and-out) + contralateral hemiparesis |
| Pons | Millard-Gubler | Ipsilateral CN VI + CN VII + contralateral hemiparesis |
| Medulla (medial) | Medial medullary | Contralateral hemiparesis + loss of proprioception/vibration; tongue deviates toward lesion (CN XII) |
UMN vs LMN
| Feature | UMN | LMN |
|---|---|---|
| Tone | Spastic | Flaccid |
| Reflexes | Hyperreflexia | Hyporeflexia / areflexia |
| Babinski | Extensor (↑) | Flexor / absent |
| Atrophy | Late, disuse | Early, severe |
| Fasciculations | No | Yes |
| Example | Stroke, MS, cord compression | Root / plexus / peripheral nerve injury |
Spinal Cord Tracts
| Tract | Carries | Lesion Effect |
|---|---|---|
| Dorsal columns (DCML) | Proprioception, vibration, fine touch | Ipsilateral loss below lesion |
| Spinothalamic | Pain, temperature | Contralateral loss 1–2 levels below |
| Corticospinal | Voluntary motor | Ipsilateral UMN signs (spastic) |
| Brown-Séquard (hemisection) | — | Ipsilateral DCML + motor; contralateral pain/temp |
Seizures — Quick Classification
| Type | Hallmark |
|---|---|
| Focal aware | No loss of consciousness (e.g. focal motor, sensory) |
| Focal impaired awareness | Automatisms, post-ictal confusion |
| Absence | Brief staring, 3 Hz spike-wave, child; hyperventilation triggers; no post-ictal |
| Generalized tonic-clonic | Tonic → clonic, cyanosis, tongue bite, post-ictal |
| Myoclonic | Brief shock-like jerks; early morning (JME) |
| Atonic | Sudden drop attacks |
| Status epilepticus | >5 min or recurrent without recovery → benzodiazepine first, then fosphenytoin / levetiracetam |
36
Glycogen Storage · Lipids · Lysosomal · Inborn Errors
Biochem / Genetics
Glycogen Storage Diseases
| Type | Enzyme Defect | Hallmark |
|---|---|---|
| I — von Gierke | Glucose-6-phosphatase | Severe fasting hypoglycemia, hepatomegaly, lactic acidosis, doll-like facies |
| II — Pompe | Acid α-glucosidase (lysosomal) | Cardiomyopathy, hypotonia; infantile death |
| III — Cori | Debranching enzyme | Hypoglycemia (milder), hepatomegaly |
| V — McArdle | Muscle phosphorylase | Exercise cramps, myoglobinuria; "second wind" |
Lipid Disorders (Fredrickson Highlights)
| Type | Defect | Finding |
|---|---|---|
| IIa — Familial hypercholesterolemia | LDL receptor defect | ↑↑ LDL, tendon xanthomas, premature CAD (arcus cornealis) |
| I (rare) | Lipoprotein lipase deficiency | Chylomicronemia → eruptive xanthomas, pancreatitis, creamy serum |
| IV | VLDL excess | ↑ TG, metabolic syndrome association |
Lysosomal Storage Diseases
| Disease | Enzyme | Classic Finding |
|---|---|---|
| Tay-Sachs | Hexosaminidase A | Cherry-red macula, neurodegeneration, startle; Ashkenazi Jewish; no hepatosplenomegaly |
| Niemann-Pick | Sphingomyelinase | Cherry-red macula + hepatosplenomegaly; foamy marrow cells |
| Gaucher | Glucocerebrosidase | Hepatosplenomegaly, bone crises, Gaucher cells, ↓ platelets |
| Hurler | α-L-iduronidase | Gargoylism, corneal clouding, hepatosplenomegaly; AR |
PKU & MSUD
| Disease | Enzyme | Hallmark | Treatment |
|---|---|---|---|
| PKU | Phenylalanine hydroxylase | Musty odor, hypopigmentation, intellectual disability; newborn screen | Dietary phenylalanine restriction (avoid aspartame) |
| Maple syrup urine disease | Branched-chain α-ketoacid dehydrogenase | Maple syrup urine odor, encephalopathy, hypoglycemia | Leucine restriction; thiamine |
37
Epidemiology Measures · Screening · Prevention · EPI
Community Medicine
Epidemiology — Core Measures
| Measure | Definition |
|---|---|
| Incidence | New cases in a period ÷ population at risk — measures risk |
| Prevalence | All existing cases ÷ population — affected by incidence × duration |
| Attack rate | Cases ÷ exposed population during an outbreak (a type of incidence) |
| Relative risk (RR) | Risk in exposed ÷ risk in unexposed — cohort studies |
| Odds ratio (OR) | Exposure odds in cases ÷ controls — case-control studies (approximates RR for rare disease) |
| Attributable risk | Risk in exposed − risk in unexposed (excess risk due to exposure) |
| Number needed to treat | 1 ÷ absolute risk reduction |
Screening Metrics (2×2)
| Metric | Formula | Intuition |
|---|---|---|
| Sensitivity | TP ÷ (TP + FN) | Proportion of diseased correctly detected; high = few false negatives (rule-out) |
| Specificity | TN ÷ (TN + FP) | Proportion of healthy correctly excluded; high = few false positives (rule-in) |
| PPV | TP ÷ (TP + FP) | If test positive, chance the disease is truly present — falls as prevalence falls |
| NPV | TN ÷ (TN + FN) | If test negative, chance the patient is truly disease-free |
| Accuracy | (TP + TN) ÷ total | Overall correct classification |
Study Designs
| Design | Direction | Strength / Use |
|---|---|---|
| Cross-sectional | Snapshot (prevalence) | Describes prevalence; can't establish temporality |
| Case-control | Backward (outcome → exposure) | Rare diseases, fast, cheap; uses OR; recall bias |
| Cohort | Forward (exposure → outcome) | Incidence + RR; good for common outcomes; long, costly |
| RCT | Intervention, randomized | Best for causation; eliminates confounding; blinding; ethical limits |
Prevention Levels
| Level | Target | Examples |
|---|---|---|
| Primary | Healthy individuals | Vaccination, hand hygiene, healthy diet, seatbelts |
| Secondary | Early disease | Screening — mammography, BP checks, Pap smear |
| Tertiary | Established disease | Rehabilitation, complication control, physiotherapy |
EPI Schedule — Pakistan (simplified)
| Age | Vaccines |
|---|---|
| Birth | BCG, OPV-0, Hep B-1 |
| 6 weeks | Pentavalent-1, OPV-1, IPV-1, PCV-10-1, Rotavirus-1 |
| 10 weeks | Pentavalent-2, OPV-2, IPV-2, PCV-10-2, Rotavirus-2 |
| 14 weeks | Pentavalent-3, OPV-3, IPV-3, PCV-10-3, Rotavirus-3 |
| 9 months | Measles-1 (MR-1) |
| 15 months | Measles-2 (MR-2) |
| Typhoid conjugate | 9 months (single dose, newer addition) |
38
ACS · Arrhythmias · AV Blocks · Heart Failure
Cardiology
Acute Coronary Syndromes
| Entity | ECG | Biomarker | Management |
|---|---|---|---|
| STEMI | ST elevation, later Q waves | Troponin ↑ | Reperfusion — primary PCI (or fibrinolysis if PCI >120 min) |
| NSTEMI | No ST elevation (ST depression / T inversion) | Troponin ↑ | Antithrombotic + early invasive strategy for high risk |
| Unstable angina | No ST elevation | Troponin normal | Same pathway as NSTEMI (medical first) |
| All ACS | — | — | MONA + antiplatelets (aspirin + P2Y12), anticoagulant, statin, beta-blocker |
Arrhythmias — ECG Recognition
| Rhythm | Feature | Treatment |
|---|---|---|
| Atrial fibrillation | Irregularly irregular, no P waves, narrow QRS | Rate/rhythm control + anticoagulation (CHA₂DS₂-VASc) |
| Atrial flutter | Sawtooth flutter waves (250–350/min) | Rate control; ablation is curative |
| PSVT / SVT | Regular narrow complex, no visible P, sudden onset | Vagal maneuvers → adenosine → CCB |
| VT | Wide QRS, monomorphic, no capture/fusion beats | Amiodarone; cardioversion if unstable |
| VF | Chaotic, no cardiac output (arrest) | Defibrillation + CPR (ACLS) |
| Torsades de pointes | Polymorphic VT, long QT | MgSO₄; correct QT causes |
AV Blocks
| Degree | ECG Finding | Management |
|---|---|---|
| 1st degree | PR >200 ms, all conducted | Observe (usually benign) |
| 2nd — Mobitz I (Wenckebach) | PR progressively lengthens → dropped beat | Observe (AV nodal — often reversible) |
| 2nd — Mobitz II | Sudden dropped beats, constant PR | Pacemaker (infranodal — may progress) |
| 3rd degree (complete) | P waves and QRS dissociated | Pacemaker (emergency if symptomatic) |
Heart Failure — NYHA + GDMT
| NYHA Class | Limitation (ordinary activity) |
|---|---|
| I | None — no symptoms with normal activity |
| II | Slight — comfortable at rest, symptoms with ordinary exertion |
| III | Marked — comfortable at rest, symptoms with minimal exertion |
| IV | Severe — symptoms at rest |
| Drug (HFrEF) | Mortality Benefit |
|---|---|
| ARNI (sacubitril/valsartan) or ACE-I/ARB | Yes — cornerstone neurohormonal blockade |
| Beta-blocker (carvedilol, bisoprolol, metoprolol XL) | Yes — start after euvolaemia |
| MRA (spironolactone / eplerenone) | Yes — watch K⁺ and renal function |
| SGLT2 inhibitor (empagliflozin, dapagliflozin) | Yes — regardless of diabetes |
| Digoxin / diuretics | Symptom benefit only — no mortality benefit |
39
ABG · Anion Gap · MUDPILES · Sodium / Potassium
Acid-Base
ABG — First Pass Interpretation
| pH | pCO₂ | HCO₃ | Diagnosis |
|---|---|---|---|
| Low | High | Normal | Respiratory acidosis (hypoventilation) |
| Low | Normal | Low | Metabolic acidosis (anion gap?) |
| High | Low | Normal | Respiratory alkalosis (hyperventilation) |
| High | Normal | High | Metabolic alkalosis (vomiting, diuretics) |
| Normal | Abnormal | Abnormal | Mixed disorder — check compensation & delta gap |
Anion Gap & MUDPILES
| Mnemonic | Cause |
|---|---|
| M | Methanol (osmolal gap) |
| U | Uremia (renal failure) |
| D | Diabetic ketoacidosis |
| P | Propylene glycol |
| I | Isoniazid / Iron |
| L | Lactate (sepsis, ischemia) |
| E | Ethylene glycol (oxalate crystals) |
| S | Salicylates (also resp. alkalosis) |
Anion gap = Na⁺ − (Cl⁻ + HCO₃⁻), normal ≈ 8–12. Winter's formula: expected pCO₂ = 1.5 × HCO₃ + 8 ± 2. Delta gap: ΔAG ÷ ΔHCO₃ — >1 suggests concurrent metabolic alkalosis, <1 a non-gap acidosis.
Sodium Disorders
| Disorder | Causes | Correction Rule |
|---|---|---|
| HypoNa⁺ (dilutional) | SIADH, heart/liver/renal failure, polydipsia | Fluid restrict; do not correct >8–10 mEq/L per 24h (osmotic demyelination) |
| HypoNa⁺ (depletional) | Diuretics, vomiting, diarrhea, adrenal insufficiency | Normal saline; replace slowly |
| HyperNa⁺ | Water loss (diabetes insipidus), hypertonic saline | Free-water replacement; correct slowly |
Potassium Disorders
| Disorder | Causes | ECG / Treatment |
|---|---|---|
| HyperK⁺ | Renal failure, ACE-I/ARB, K⁺-sparing diuretics, hemolysis, acidosis | Peaked T waves → wide QRS; Ca²⁺ gluconate (membrane), insulin + glucose, kayexalate, dialysis |
| HypoK⁺ | Diuretics, vomiting, diarrhea, aldosterone excess, insulin | U waves, flat T, arrhythmia; oral/IV replacement (never rapid IV bolus) |